- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 01 March 2023
-
Current Status:
Answered by Humza Yousaf on 15 March 2023
To ask the Scottish Government what assessment it has made of the adequacy of current staffing levels for lung cancer nurse specialists within the (a) West of Scotland Cancer Network, (b) North Cancer Alliance and (c) South East Scotland Cancer Network.
Answer
The Scottish Government has overall responsibility for health and social care policy in Scotland, however the statutory responsibility for delivering or commissioning services lies with health boards. Operational decisions, including whether there is a need for lung cancer specialist nurses, is therefore, a matter for them.
Scottish Government officials have weekly cancer calls with health boards where issues with staffing can be addressed and supported.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 01 March 2023
-
Current Status:
Answered by Humza Yousaf on 15 March 2023
To ask the Scottish Government what assessment it has made of how many new lung cancer patients per whole-time equivalent lung cancer nurse specialist there were in September (a) 2020, (b) 2021 and (c) 2022.
Answer
The Scottish Government does not hold this information centrally.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 01 March 2023
-
Current Status:
Answered by Humza Yousaf on 15 March 2023
To ask the Scottish Government what steps it is taking to support NHS Scotland to train new lung cancer nurse specialists to support the reported increasing number of lung cancer patients living five years or more following diagnosis.
Answer
The Scottish Government is committed to training Clinical Nurse Specialists. The Specialist Nursing and Care Report details how health boards have used the £2.5 million recurring funding announced in 2015 to enhance clinical nurse specialist in NHS Scotland.
We set out in Transforming Nursing, Midwifery And Health Profession (NMaHP) roles: review of Clinical Nurse Specialist and Nurse Practitioner roles within Scotland , published in August 2021, how health boards can use a flexible approach to the education and training of Clinical Nurse Specialists. Education programmes can be provided through higher education institutions as well as modules provided by health boards; work based learning for training posts that have a specific specialisms with appropriate supervision; and digital learning to maximise access and flexibility to training.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 01 March 2023
-
Current Status:
Answered by Humza Yousaf on 15 March 2023
To ask the Scottish Government what steps it is taking to increase the number of lung cancer nurse specialists.
Answer
The Scottish Government is committed to ensuring that all people living in Scotland with lung cancer are able to access the best possible care and support, and benefit from healthcare services that are safe, effective and put people at the centre of their care.
Clinical nurse specialists make a valued contribution to delivering services and supporting patients and families who require specialist care. The Scottish Government has invested over £2.4 million annually in the Specialist Nursing and Care Fund since 2015.
The Scottish Government has overall responsibility for health and social care policy in Scotland; however, the statutory responsibility for delivering or commissioning services at a local level lies with local authorities, NHS Boards and integrated health and social care partnerships. Operational decisions, including whether there is a need for lung cancer specialist nurses, are therefore matters for those bodies.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 15 February 2023
-
Current Status:
Taken in the Chamber on 22 February 2023
To ask the Scottish Government what steps it is taking to increase the number of student nurses.
Answer
Taken in the Chamber on 22 February 2023
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 16 January 2023
-
Current Status:
Taken in the Chamber on 19 January 2023
To ask the First Minister what progress the Scottish Government has made in clearing the reported backlog of people waiting for key diagnostic tests.
Answer
Taken in the Chamber on 19 January 2023
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Tuesday, 06 December 2022
-
Current Status:
Answered by Humza Yousaf on 16 December 2022
To ask the Scottish Government how many delayed breast reconstruction operations have been carried out in 2022, broken down by (a) month and (b) NHS board.
Answer
This information is not held centrally. Public Health Scotland do not hold the information that would allow us to identify the amount of delayed breast reconstruction operations that have been carried out in 2022, broken down by month and NHS Board.
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Monday, 05 December 2022
-
Current Status:
Answered by Humza Yousaf on 13 December 2022
To ask the Scottish Government, for its (a) Alcohol Harm Prevention Policy Team, (b) Alcohol Treatment Policy Team and (c) Drugs Policy Unit, how many posts there are in each team, and of these, how many are currently filled.
Answer
As of 12th December 2022 there are:
(a) 7 posts in the Alcohol Harm Prevention Team, all posts are currently filled
(b) 4 posts in the Alcohol Treatment Policy Team, with 3 posts filled
(c) 46 posts in the Drugs Policy Division, with 44 posts filled
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Wednesday, 07 December 2022
-
Current Status:
Taken in the Chamber on 15 December 2022
To ask the Scottish Government what its response is to the open letter signed by over 500 businesses asking for the Deposit Return Scheme to be delayed beyond next summer.
Answer
Taken in the Chamber on 15 December 2022
- Asked by: Sue Webber, MSP for Lothian, Scottish Conservative and Unionist Party
-
Date lodged: Thursday, 10 November 2022
-
Current Status:
Answered by Humza Yousaf on 28 November 2022
To ask the Scottish Government what the annual budget was for each of the NHS Research Scotland research networks and speciality groups, in each year since 2016.
Answer
Since 2016, Scottish Government Chief Scientist Office has provided a total of approximately £3.8 million to £4.3 million each year for all NRS Networks and Specialty Groups. Figures for individual Networks and Specialty Groups are indexed by financial year in the table provided.
Table 1. CSO allocations to NRS Networks and Specialty Groups since 2016-17.
Network / Specialty | FY 2016-17 | FY 2017-18 | FY 2018-19 | FY 2019-20 | FY 2020-21 | FY 2021-22 | FY 2022-23 | Total per area |
Cancer * | £442,000 | £447,000 | £456,000 | £456,000 | £456,000 | £475,000 | £475,000 | £3,207,000 |
Stroke | £598,000 | £604,000 | £616,000 | £616,000 | £616,000 | £641,000 | £641,000 | £4,332,000 |
Children | £411,000 | £415,000 | £423,000 | £423,000 | £423,000 | £441,000 | £441,000 | £2,977,000 |
Dementia | £491,000 | £496,000 | £506,000 | £506,000 | £506,000 | £677,000 | £677,000 | £3,859,000 |
Diabetes | £579,000 | £585,000 | £597,000 | £606,000 | £615,000 | £640,000 | £640,000 | £4,262,000 |
Primary Care | £385,000 | £409,000 | £440,000 | £450,000 | £484,000 | £482,000 | £482,000 | £3,132,000 |
Mental Health | £498,000 | £503,000 | £508,000 | £540,000 | £548,000 | £570,000 | £570,000 | £3,737,000 |
Cardiovascular | £64,000 | £65,200 | £66,424 | £66,424 | £66,424 | £68,923 | £68,923 | £466,318 |
Musculoskeletal | £64,000 | £65,200 | £66,424 | £66,424 | £66,424 | £81,744 | £81,744 | £491,960 |
Reproductive Health & Childbirth | £64,000 | £65,200 | £66,424 | £66,424 | £66,424 | £68,923 | £68,923 | £466,318 |
Oral and Dental | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,822 | £14,822 | £101,056 |
Age and Ageing | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Trauma and Emergencies | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Critical Care and Anaesthesia | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Peri-operative Pain | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Dermatology | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Gastrointestinal | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Hepatology | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Respiratory Disorders | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Clinical Genetics | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Metabolic & Endocrine Disorders | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Opthalmology | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Non-Malignant Haematology | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £4,000 | £90,233 |
Infectious Diseases & Microbiology | £14,000 | £14,200 | £14,404 | £14,404 | £24,808 | £14,821 | £14,821 | £111,458 |
Renal Disorders | £14,000 | £14,200 | £14,404 | £14,404 | £14,404 | £14,821 | £14,821 | £101,054 |
Total per Financial Year | £3,806,000 | £3,867,600 | £3,961,332 | £4,012,332 | £4,073,736 | £4,367,906 | £4,357,085 | £28,445,991 |
* From 1 April 2006 a recurring investment of £500,000 was incorporated into the NHS Boards unified budgets which would be subject to the annual uplift applied to Boards baseline budget